Biologic agents licensed for severe asthma: A systematic review and meta-analysis of randomised controlled trials

Conclusions: Biologic agents reduced exacerbations and symptoms, increased lung function, and improved quality of life in severe asthma, with acceptable safety profile.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Kyriakopoulos, C., Gogali, A., Markozannes, G., Potonos, D., Bellou, V., Ntritsos, G., Kostikas, K. Tags: Airway pharmacology and treatment Source Type: research